EX-32.2 5 ex32_2.htm CERTIFICATION MADE PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002. ex32_2.htm


 
 
Exhibit 32.2
 
 
Certification of Chief Financial Officer
Pursuant to 18 U.S.C Section 1350,
As Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
 
Not Filed Pursuant to the Securities Exchange Act of 1934
 
In connection with the Annual Report of Ohr Pharmaceutical, Inc. (the “Company” ) on Form 10-K for the period ending September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof  (the “Report” ), I, Sam Backenroth , Chief Financial Officer, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated: January 9, 2013
 
/s/ Sam Backenroth
 
Name:  Sam Backenroth
 
Title:   Chief Financial Officer